You just read:

AbbVie Presents Phase 2 Results from Study of Investigational Medicine Veliparib in Patients with Non-Small Cell Lung Cancer at the American Society of Clinical Oncology Annual Meeting

News provided by

AbbVie

01 Jun, 2015, 13:00 BST